Invega trinza and Pain - a phase IV clinical study of FDA data

Summary:

Pain is reported as a side effect among people who take Invega trinza (paliperidone palmitate), especially for people who are male, 40-49 old, have been taking the drug for 5 - 10 years also take Imuran, and have Schizophrenia.

The phase IV clinical study analyzes which people have Pain when taking Invega trinza. It is created by eHealthMe based on reports of 4,027 people who have side effects when taking Invega trinza from the FDA, and is updated regularly.

What is Invega trinza?

Invega trinza has active ingredients of paliperidone palmitate. eHealthMe is studying from 4,035 Invega trinza users. Check the latest studies of Invega trinza.

What is Pain?

Pain is found to be associated with 3,815 drugs and 5,866 conditions by eHealthMe. Check the latest studies of Pain.

On Jul, 19, 2026

4,027 people reported to have side effects when taking Invega trinza.
Among them, 26 people (0.65%) have Pain.

Among these 26 people:

How long have people been on Invega trinza when they have Pain? *

What is the gender of people who have Pain when taking Invega trinza? *

female: 47.62 %
male: 52.38 %

What is the age of people who have Pain when taking Invega trinza? *

What are other drugs people take besides Invega trinza? *

What are other side effects people have besides Pain? *

Inflammation: 9 people, 34.62%
Arrhythmias (irregular heartbeat): 6 people, 23.08%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 6 people, 23.08%
Hyperaesthesia: 5 people, 19.23%
Mobility Decreased (ability to move is reduced): 5 people, 19.23%
Coordination Abnormal (abnormal movement): 5 people, 19.23%
Muscle Twitching: 5 people, 19.23%
Peripheral Swelling: 5 people, 19.23%
Oromandibular Dystonia (affecting the ability to chew, speak and swallow): 5 people, 19.23%
Gait Disturbance: 5 people, 19.23%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 26.92%
Schizoaffective Disorder Depressive Type (mental illness featuring schizophrenia and a mood disorder): 5 people, 19.23%
Diabetes: 5 people, 19.23%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 15.38%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 3 people, 11.54%
Dyskinesia (abnormality or impairment of voluntary movement): 2 people, 7.69%
Substance-Induced Psychotic Disorder: 1 person, 3.85%
Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 1 person, 3.85%
Memory Loss: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Invega trinza and have Pain?

- Check whether Pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invega trinza:

Invega trinza (4,035 reports)

Pain treatments and more:

Pain (1,140,594 reports)

Browse all side effects of Invega trinza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain:

Pain (3,815 drugs)

Browse all the conditions that are associated with Pain:

Pain (5,866 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone palmitate (the active ingredients of Invega trinza) and Invega trinza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.